Fragments of the ϳ50 kDa COOH-terminal region of phospholipase C-␤1 (PLC-␤1 1 ), ranging in size from 14 to 38 kDa, were expressed in Escherichia coli, purified, and tested for their regulatory activities. As expected, none of the fragments had phospholipase activity. Several fragments, referred to as PLC tails, displayed GTPaseactivating protein (GAP) activity for G q , the G protein class that stimulates the PLC-␤s in response to receptors. G q GAP activity is characteristic of intact PLC-␤s. In reconstituted phospholipid vesicles that contained purified G q and m1 muscarinic cholinergic receptors, the most active tails increased agonist-stimulated, steady-state GTPase activity over 4-fold. Stimulation of steady-state GTPase by the tails depended on receptors for facilitation of GDP-GTP exchange, suggesting that the tails act by accelerating hydrolysis of bound GTP. In addition to intrinsic GAP activity, one tail with high GAP activity and others with low or minimal activity potentiated the GAP activity of intact PLC-␤1. Other tails inhibited PLC-␤1s GAP effect. Both intrinsic GAP activity and potentiation of the PLC-␤1 GAP effect were often biphasic, with maxima as low as 100 nM tail and declining activities at higher concentrations. Several tails inhibited either the phospholipase activity of PLC-␤1, its stimulation by G q , or both. The tails thus define the region of PLC-␤1 that has G q GAP activity and suggest a mechanism of action in which the COOH terminus of PLC-␤s can interact with G q and with other PLC-␤1 molecules.
The PIP 2 -specific 1 phospholipase Cs (PLCs) generate the second messengers inositol 1,4,5-trisphosphate and diacylglycerol in response to numerous and diverse stimuli. The PLC-␤ isoforms respond to receptor-activated G proteins and do so by two different mechanisms. G␣ subunits of the G q class stimulate all of the PLC-␤s so far described (1) (2) (3) (4) and account for pertussis toxin-insensitive inositol 1,4,5-trisphosphate release. Pertussis toxin-sensitive stimulation is mediated by the G␤␥ subunits, is probably confined to PLC-␤2 and PLC-␤3, and is usually a smaller effect (1, (5) (6) (7) (8) . The G␤␥ is most typically released at significant concentrations from activated G i .
In addition to generating inositol 1,4,5-trisphosphate and diacylglycerol, the PLC-␤s are GTPase-activating proteins (GAPs) for the G q s. PLC-␤ accelerates hydrolysis of G q -bound GTP by about 100 -300-fold (9) , thus increasing the speed at which signal is terminated upon removal of agonist. G q GAP activity also modulates signal amplitude and has the potential to increase the operational selectivity of receptor-G protein recognition (9 -11) .
The common responsiveness of the PLC-␤ isoforms to G q and their G q GAP activity suggest that they share one or more structural domains that bind G q . Defining such a region, or regions, would be valuable for several reasons. First, the currently recognized G␣-regulated effectors, adenylyl cyclases, PLC-␤s, and cyclic GMP phosphodiesterase, bear no obvious sequence similarity. No hint of a common G␣ recognition domain has emerged. Second, definition of a relatively small and well defined domain in PLC-␤ that modulates its G q GAP activity may allow construction of mutant PLC-␤s that lack GAP activity. Such mutants would in turn allow definition of the physiologic effects of GAP-stimulated GTP hydrolysis in cells. Last, definition of a GAP domain may allow design of small GAPs without PLC activity that would be useful for in vitro enzymologic experiments and for modulating G q activation in cells.
The PLC-␤s share three broadly defined regions of sequence similarity. The central X and Y regions are found in all PIP 2specific PLCs and include the active site and PIP 2 -binding C2 domain (12, 13) . A COOH-terminal domain of about 50 kDa is not found in the other PLCs. Sequence similarity among the PLC-␤s in the COOH-terminal domain varies from negligible in some regions to consistent identity in others (see Fig. 1 ). Both COOH-terminal proteolysis and genetic truncation of PLC-␤ indicate that removal of the COOH-terminal 180 residues renders PLC-␤1 insensitive to stimulation by G q (14, 15) . Based on these findings, we expressed a series of protein fragments based on the sequence of the COOH-terminal region of PLC-␤1, which we refer to as PLC tails. Tail proteins were purified and assayed for their ability to interact with PLC and G q . Several of the tails possess intrinsic G q GAP activity and inhibit the interaction of intact PLC-␤1 with G q . They thus define the GAP domain of the PLC-␤s with some precision.
EXPERIMENTAL PROCEDURES
Construction of COOH-terminal Fragments of PLC-␤1-cDNAs corresponding to fragments of the COOH-terminal region of rat PLC-␤1 (see Fig. 1 ) were ligated into the bacterial expression vectors pQE-30 or pQE-32 (Qiagen Inc.), which include six His codons before the multiple cloning site. The XmaI fragment (nucleotides 2741-3934 of the PLC-␤1 cDNA) (16) was excised and ligated into pQE-32. This cDNA, tail 1, was used for further constructs, referred to as "tails." To construct tail 3, the tail 1 vector was digested with SphI and HpaI, treated with mung bean nuclease to convert the protruding termini to blunt ends, and then religated. For the construction of tail 5, the tail 1 vector was digested with HincII, and the resulting 600-base pair fragment was ligated into the SmaI site of pQE-30. Tail 32 was constructed from tail 3 by digestion with PstI and religation. Tail 52 was constructed by digestion of tail 5 with PstI and religation. Tail 35 (nucleotides 2917-3336) was produced by polymerase chain reaction, with unique restriction sites for BamHI and HindIII to allow in-frame ligation of the polymerase chain reaction fragment into pQE-30. All constructs have the His 6 tag at the NH 2 terminus.
Protein Purification-The different tail plasmids were co-transformed with pREP4 into different bacterial hosts (tail 3, tail 5, tail 52, and tail 32 into M15 and tail 35 into JM109). Multiple copies of pREP4 present in the host cells ensure high levels of lac repressor and tight regulation of protein expression (17) . For production of protein, one liter of T7 medium that contained ampicillin (50 g/ml), kanamycin (25 g/ml), and 2% glucose (17) was inoculated with 20 ml of an overnight culture. Cells were grown at 37°C for 2-4 h, 60 M isopropyl ␤-Dthiogalactopyranoside was added, and cells were grown further for 2-6 h at 30°C, dependent on the construct. Bacteria were harvested by centrifugation for 12 min at 4°C at 5000 ϫ g, frozen in liquid N 2 , and stored at Ϫ80°C.
Bacteria were thawed on ice and incubated with 1 mg/ml lysozyme in sonication buffer (50 mM NaP i , pH 7.5, 300 mM NaCl, 10% glycerol, 1 g/ml aprotinin, 10 g/ml leupeptin, and 0.1 mM phenylmethylsulfonyl fluoride) for 30 min on ice. After sonication (3 ϫ 1 min bursts at 300 -400 W), the suspension was centrifuged at 4°C at 15,000 ϫ g for 30 min. 2-Mercaptoethanol (10 M final) and Ni-NTA resin (Qiagen) were added to the supernatant, and the mixture was stirred on ice for 1 h. The resin was washed to zero absorbance at 280 nm in a chromatographic column with sonication buffer that included NaCl and/or imidazole in the following order: 1 M NaCl, 1 M NaCl plus 20 mM imidazole, 300 mM NaCl plus 20 mM imidazole. The remaining proteins on the column were then eluted with sonication buffer that contained 300 mM NaCl and 150 mM imidazole. The eluate was concentrated by ultrafiltration (Amicon PM 10), diluted 10-fold with MonoQ buffer (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 10% glycerol, 1 g/ml aprotinin, and 10 g/ml leupeptin) and applied to a column of MonoQ agarose. Most of the tails did not bind to the MonoQ column, and the flow-through and wash was pooled and concentrated by ultrafiltration. Tail 5 did bind and was eluted with a gradient of 10 -60 mM NaCl in MonoQ buffer. The fractions that contained each tail were concentrated, diluted 10-fold with MonoS buffer (20 mM Na MES, pH 6.0, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 10% glycerol, 1 g/ml aprotinin, and 10 g/ml leupeptin), and applied to MonoS agarose. The gradient for MonoS chromatography was 10 mM to 1 M NaCl for all tails except tail 3, where the gradient was from 40 mM to 900 mM NaCl. The different tail proteins eluted at the following NaCl concentrations: tail 3, 540 -660 mM NaCl; tail 5, 600 -740 mM NaCl; tail 52, 470 -570 mM NaCl; and tail 32, 880 -1 M NaCl. MonoS chromatography followed MonoQ for all tails except for tail 35, where the order was reversed. Purification of the tails was monitored by SDS-polyacrylamide gel electrophoresis. Peak fractions were pooled and concentrated by ultrafiltration. Concentrations of purified tails were estimated by Amido Black staining (18) . The purified tails were subjected to polyacrylamide gel electrophoresis in SDS according to Ref. 19 and visualized by silver staining (20) . The proteins were quick-frozen in liquid N 2 and stored at Ϫ80°C until further use. M1 muscarinic cholinergic receptor, PLC-␤1, and G q ␣ and ␤␥ subunits were expressed in Sf9 cells and purified as described previously (9, (21) (22) (23) .
Reconstitution-Receptor and G protein were co-reconstituted into phospholipid vesicles by gel filtration of a mixture of proteins and lipids in detergent solution, as described previously (9, 10) . Vesicles were incubated with 5 mM dithiothreitol at 0°C for 1 h to activate receptors (24) . PLC-␤1, tails, or their buffer were added prior to assay. Other methods have been described previously (10) .
Miscellaneous Assays-M1 muscarinic cholinergic receptor was assayed by [ 3 H]quinuclidinylbenzilate binding (25) . Total G q was measured according to bound GDP, which was assumed to be 1 mol/mol (25, 26) . After reconstitution, receptor-accessible G q was measured according to carbachol-stimulated GTP␥S binding (9) . [ 35 S]GTP␥S binding and steady-state GTPase were measured as described previously (9) .
PLC Activation-Activation of PLC-␤1 by G q and/or Ca 2ϩ was determined by minor modifications of the method of Blank et al. (27) , which measures hydrolysis of [ 3 H]PIP 2 added as mixed micelles. The reaction (100 l) was initiated with the indicated amounts of purified PLC-␤1 (10 l) and continued for 15 min at 37°C. Stimulation of PLC-␤1 by G q was measured by first activating G q for 1 h at 30°C in the presence of 1 mM GTP␥S and then measuring the activity of PLC-␤1 (0.65 nM) in the presence of 10 ng of activated G q , 0.1 mM GTP␥S, 1.2 M free Ca 2ϩ , and 0.1% cholate. Stimulation by Ca 2ϩ was measured in the presence of 23 M free Ca 2ϩ . Concentrations of free Ca 2ϩ were maintained with EGTA buffers prepared according to published dissociation constants (28) and a multiple equilibrium program generously provided by Dr. Andrew Blatz (Axon Instruments, Inc.).
Immunoblotting-Purified PLC-␤1 and tail proteins were resolved on SDS-polyacrylamide gels (19) , transferred to nitrocellulose, and detected exactly as described previously (25) . Antibodies against PLC-␤1 were prepared using synthetic peptide antigens coupled to hemocyanin with m-maleimidobenzoyl-N-hydroxysuccinimide ester (29) . The two peptides covered amino acid residues 1046 -1077 and 1049 -1060. Tail 35 does not include these sequences and was therefore detected using a mixture of monoclonal antibodies against PLC-␤1 that was kindly provided by Sue-Goo Rhee (NHLBI) (30) .
Materials-[␥-32 P]GTP was synthesized and purified as described previously (9) 
RESULTS
Because of the likely regulatory importance of the COOHterminal extension of the PLC-␤s, we prepared and expressed several cDNAs that encode peptides with sequences from this region of PLC-␤1 ( Fig. 1 ). The peptides covered 314 amino acid residues and included the four identifiable regions of highest sequence conservation in the PLC-␤ family. Each of the peptides was ultimately expressed in Escherichia coli as a soluble cytosolic protein and all except tail 1 were purified at acceptable levels. However, the peptides varied markedly in their levels of expression and their toxicity, such that it was necessary to choose different host strains and to optimize induction conditions for each cDNA construct. Each tail peptide contained a His 6 tag to facilitate purification, and each was highly purified using the same three chromatographic steps ( Fig. 2 and "Experimental Procedures"). Preparations of tails were essentially free of GTPase activity (less than 10 Ϫ5 mol GTP hydrolyzed min Ϫ1 ⅐mol Ϫ1 or ϳ1% of basal in Fig. 3 ). The identity of each tail was confirmed before and after purification by Western blotting with either peptide-generated or monoclonal antibodies (not shown). The largest tail for which cDNAs were prepared, shown in Fig. 1 as tail 1, was never purified and was not included in the experiments shown here.
G q GAP Activity of PLC-␤1 Tails-The ability of the various tail peptides to act as G q GAPs was measured according to amplification of the steady-state GTPase activity of m1 receptor-G q vesicles under standard assay conditions (9). In this system, the different tails displayed diverse regulatory activities that included intrinsic G q GAP activity, potentiation of the G q GAP activity of intact PLC-␤1, and, at higher concentrations, inhibition of the PLC G q GAP activity. These activities are summarized in Fig. 3 . Although the patterns of regulation vary widely, the behavior of each tail was reproducible over multiple preparations and experiments.
Tails 3, 35, and 5 all displayed significant intrinsic G q GAP activity ( Fig. 3 ). Tail 35 was the most active G q GAP, stimulating steady-state GTP hydrolysis over 4-fold. Although the G q GAP activities of the tails are lower than that of full-length PLC-␤1, their effects are clearly substantial. The G q GAP activity of tail 35 was biphasic. Stimulation was maximal at 200 -300 nM tail 35, with an EC 50 of 50 -100 nM. (For reference, the EC 50 for full-length PLC-␤1 is ϳ2 nM (9, 10)). Stimulation declined at higher concentrations, but tail 35 was stimulatory at all concentrations tested. Tail 3 was also an active G q GAP, with an EC 50 similar to that of tail 35. Its maximal stimulation of steady-state GTPase activity was also about 4-fold. The absolute increment in GTPase activity shown for tail 3 in Fig.  3 is smaller than that for tail 35, but the difference reflects the lower GTPase activity of the vesicles. A consistent difference between tail 3 and tail 35 was that the tail 3 concentration curve displayed a plateau, with no decline in GAP activity at increasing concentrations. Tail 5 also displayed a weak G q GAP activity (Յ2-fold) and was not characterized in detail. The G q GAP activities of tails 32 and 52 were negligible. These data establish that the COOH-terminal region of PLC-␤1 between residues 903 and 1043 contain the structures necessary for G q GAP activity, although other parts of the protein contribute quantitatively to affinity for G q , overall correct folding, or both. We cannot explain the lack of GAP activity of tail 32 (residues 903-1143), which is intermediate in size between the active tails 3 and 35. We speculate that it may not fold properly to expose its potential GAP site.
Both the PLC tails and PLC-␤1 stimulated the steady-state GTPase activity of G q only in the presence of the muscarinic agonist carbachol (Fig. 3) , as described previously for PLC-␤1 (9, 10). In the absence of agonist-bound receptor, the binding of GTP to G q is a slow and rate-limiting step in the steady-state GTPase cycle. The addition of PLC-␤1 is thus without effect. However, when GTP binding is accelerated by receptor, hydrolysis becomes rate-limiting and the GAP activities of PLC-␤1 and the tails is evident.
Potentiation of the GAP Activity of Intact PLC-␤1-In addition to exhibiting intrinsic G q GAP activity on its own, addition of tail 35 also increased agonist-stimulated, steady-state GTPase activity in the presence of a significant concentration of full-length PLC-␤1. More surprisingly, tail 52, which is not a GAP, also magnified the GAP activity of the PLC-␤1. Maximal potentiation by tails 35 and 52 was usually about 40 -80% above the level produced by PLC-␤1 alone and declined with higher concentrations of tail protein. By coincidence, the GAP activities of tail 35 and PLC-␤1 shown in Fig. 3 were roughly additive below 500 nM tail 35. Because tail 52 has negligible intrinsic GAP activity, its effect was entirely ascribable to potentiation of PLC-␤1. In the experiments shown in Fig. 3 , the concentration of PLC-␤1 was 4.7 nM, about twice its EC 50 (9, 10) . To determine more clearly whether the tails were behaving cooperatively or independently with respect to PLC-␤1, the effect of tail 35 was measured in the presence of increasing concentrations of PLC-␤1 (Fig. 4) . The concentration of tail 35 in this experiment, 200 nM, was maximally stimulating. Regardless, stimulation of GTPase activity by tail 35 remained additive with respect to that by PLC-␤1 over the entire range of PLC-␤1 concentrations tested, with only minor positive deviation at the highest PLC-␤1 concentrations (about 100 times its EC 50 as a GAP).
The synergistic GTPase-stimulating activities of the tails are inconsistent with their binding as monomers only at the PLC-␤1-binding site on G q . Such competitive binding would predict the following: 1) increasing concentrations of tail 52 should monotonically inhibit the GAP activity of PLC-␤1, 2) increasing concentrations of PLC-␤1 at saturation should evoke the same GTPase activity regardless of the presence of either tail, and 3) increasing concentrations of tail 35 should either inhibit or FIG. 1. Schematic representation of intact PLC-␤1 and the tails. A, in the diagram of the intact PLC-␤1, the boxes marked X and Y indicate the conserved catalytic and C2 domain conserved among all the PIP 2 -specific PLC isozymes (12, 13) , and the solid bar is the COOH-terminal region from which the tails were constructed. Filled boxes below represent COOH-terminal proteins referred to as tails 1, 3, 5, 52, 32, and 35, with their termini shown at the bottom. Details of their construction are described under "Experimental Procedures." Sizes of the tail proteins, including the His 6 tag and residues encoded by the poly-linker regions of the vectors, are shown at the right. B, conservation of amino acid sequence among PLC-␤ isoforms. The conservation of amino acid sequence among PLC-␤1, PLC-␤2, and PLC-␤3 (12) was averaged over a moving window of nine amino acid residues. The arbitrary scoring for similarity was rigorous: identity was scored 9, two identical plus one similar was scored 3, all three very highly similar was scored 2, and all other cases were scored zero. The plot starts at residue 900 in PLC-␤1. stimulate GTPase activity dependent on the amount of PLC-␤1 present, but GTPase activity should saturate at the level characteristic of tail 35 alone. None of these predictions was supported by the data. Thus, the synergism between the tails and PLC-␤1 indicates either that the tails bind to a second site on G q to potentiate GAP activity or that the tails bind PLC-␤1 to form a hetero-oligomer with GAP activity greater than that of PLC-␤1 alone.
Blockade of the GAP Effect of PLC-␤1-At high concentrations, each of the tail proteins inhibited the GAP activity of PLC-␤1, even those that potentiated its GAP activity at lower concentrations and those that are themselves GAPs. Again, several patterns of regulation were observed (Fig. 3) . Tails 3 and 32, which do not potentiate the G q GAP activity of PLC-␤1, monotonically and completely inhibited the GAP effect of PLC-␤1, saturating at a minimum GTPase activity equal to that observed with agonist but without PLC-␤1. Thus, tail 32, which is not a GAP, inhibited GTPase activity to the level displayed by the vesicles alone; tail 3 inhibited to the level characteristic of its intrinsic G q GAP activity. Tail 5 behaved somewhat similarly to tail 3, but inhibition was far less potent (IC 50 Ն 10 M), was apparently biphasic, and could not be shown to be complete because of its low affinity. Tails 35 and 52, which potentiated the GAP activity of PLC-␤1 at low concentrations, inhibited at higher concentrations to yield a biphasic activity profile. In the case of tail 35, GTPase activity was inhibited to the level promoted by the tail itself. This pattern may also hold for tail 52, although we were unable to add enough to demonstrate complete inhibition.
Although the pattern of behaviors of the five tails is complex, they can all be characterized by some G q GAP activity (negligible to substantial) and inhibition of the GAP activity of PLC-␤1 at high concentrations. Some also potentiated the GAP effect of the PLC at low concentrations. Except for tail 52, each also acted at submicromolar concentrations, with apparent EC 50 and IC 50 values between 100 and 500 nM. The tails' GAP activities indicate their direct interactions with G q , although biphasic effects are also consistent with binding to themselves or to PLC-␤1 as homo-or hetero-oligomers. The complex activities of tails 35 and 52 essentially demand such oligomerization.
Effects of PLC Tails on the PIP 2 -specific Phospholipolytic Activity of PLC-␤1 and Its Stimulation by G q -Because the tails all lack the conserved X and Y domains, which are required for lipid hydrolysis by the PLC superfamily (12), none displayed phospholipolytic activity (data not shown). However, as was observed for GAP activities, the tails displayed diverse regulatory behaviors when assayed for their effects on the phospholipolytic activity of intact PLC-␤1 ( Figs. 5 and 6 ).
Among the five tails studied, four uniformly inhibited the activity of PLC-␤1 when lipolysis was stimulated by Ca 2ϩ : tails 3, 32, 5, and 52 ( Fig. 5) . Inhibition was substantial for all four tails: 70 -90% at apparent saturation. Tail 35 alone displayed the biphasic behavior shown in Fig. 5 : initial stimulation of PIP 2 hydrolysis below 200 nM followed by substantial (Ն80%) inhibition at higher concentrations. In general, inhibition of PLC-␤1 by the tails occurred over the same ranges of concentrations where they displayed their effects on the G q -catalyzed GTPase reaction. Tails 32 and 35 acted at lower concentrations than the others, and tails 5 and 52 were the least potent. Although the shapes of the inhibition curves varied among the four tails that were solely inhibitory, sometimes appearing markedly biphasic, we have not pursued the concentration dependence of inhibition beyond experiments of the sort shown in Fig. 5 .
The data of Fig. 5 do not indicate whether inhibition of PIP 2 hydrolysis by the tails results from their direct interactions with PLC-␤1 or from effects on the substrate vesicles. However, the similar concentration dependences for GAP activity, GAP potentiation, and inhibition of phospholipolysis ( Figs. 3 and 5) argue for an effect on PLC-␤1. Note also that all experiments were performed in the presence of 9 M bovine serum albumin, which would be expected to bind nonspecifically to hydrophobic surfaces.
When the phospholipase C activity of PLC-␤1 was assayed under stimulation by GTP␥S-activated G q , the tails displayed a different array of behaviors than observed under stimulation by Ca 2ϩ (Fig. 6 ). Tails 5, 52, and 35 were either inactive or slightly stimulatory. Only tails 3 and 32 remained strong inhibitors of PIP 2 hydrolysis when PLC-␤1 was stimulated by activated G q . This change in behavior of three tails argues strongly that their effects are not merely on the lipid substrate and that their inhibition of PLC-␤1 can be overcome by G q . The tails thus appear to interact at a distinct regulatory site on the intact PLC-␤1. Their GAP activity argues that they also bind to a regulatory site on G q .
DISCUSSION
The interface between PLC-␤1 and G q ␣ conveys regulatory information in two directions. GTP-activated G q ␣ stimulates the phospholipolytic activity of PLC-␤1, and PLC-␤1 stimulates hydrolysis of GTP bound to G q ␣. This interface is therefore of basic structural interest. In addition, its functional map can potentially explain the basis of PLC-␤'s selectivity for the G q class of G␣ subunits. Last, such a map should provide the basic structure-function data needed to design both small peptides with G q GAP activity and mutant PLC-␤s that respond to G q but are not GAPs. Both such reagents will be valuable in studying the role of GAP activity in receptor-G q -PLC signaling in cells.
The studies reported here depict a complex set of structurefunction relationships for the COOH terminus of PLC-␤1. They identify sequences responsible for G q GAP activity but also describe more complex interactions that suggest homooligomerization sites within the PLC-␤1 COOH terminus (Table I) .
First, the G q GAP activity of tail 35, PLC-␤1 residues 903-1042, defines an independently stable G q GAP domain with high affinity for G q (EC 50 ϭ ϳ100 nM). This domain is relatively small (16.7 kDa exclusive of vector-encoded sequence), 75% hydrophilic, strongly basic (calculated pI ϭ 9.9), and predicted to be mostly ␣-helical. Tail 35 contains the first two regions of strong sequence conservation among the COOH termini of the PLC-␤ family (residues 910 -930 and 1015-1030), but excludes the second two (residues 1055-1130). Tail 35 thus delineates at least one site of PLC-␤1 contact with G q and should form the basis for finer mapping of sites needed for G q binding and GAP activity.
The maximum GAP activity of tail 35 is only about 15-20% that of intact PLC-␤1 as measured in the steady-state GTPase assay, and its potency is lower, but its activity and potency are still substantial. The decrease in maximum GAP activity in part is another reflection of a lower affinity for G q . Efficient amplification of steady-state GTPase activity requires high affinity binding to G q throughout its GTPase cycle (9) , and the lower maximum GAP activity of the tail may reflect its dissociation from the GDP-bound form of G q . The loss of affinity for G q may only reflect the fact that tail 35 does not bind to membranes and is therefore not concentrated at the surface of the vesicles, but it may also lack a second G q contact site.
Tail 35 is included within the approximately 50-kDa COOHterminal region of PLC-␤1 previously shown by mutagenesis and proteolysis to be required for responsiveness to G q (14, 15) . Based on the behavior of a COOH-terminal truncation mutant and on inhibition of G q regulation by two synthetic peptides, Wu et al. (14) further suggested that a small, also cationic region COOH-terminal to tail 35 is required for regulation by G q . Our data neither support nor contradict this suggestion. However, it is possible that the loss of G q responsiveness in some of the inactive, shorter truncation mutants reflects misfolding or proteolysis rather than deletion of important COOHterminal sequence. Such misfolding probably explains why tail 32 is not a G q GAP even though it is midway in length between tail 3 and tail 35, both of which are active GAPs. Unpurified samples of the two peptides from the distal COOH-terminal region, shown by Wu et al. to inhibit stimulation of PLC-␤1 by G q , did not display G q GAP activity (data not shown).
In addition to binding and regulating G q , the tails also appear to interact with themselves and with full-length PLC-␤1 and thereby modulate both G q GAP and phospholipase activities. If this suggestion is true, then intact PLC-␤1 may also form homo-oligomers through COOH-terminal contact points. Other data suppporting oligomerization of PLC-␤ have so far been sketchy. Paterson et al. found that increasing the concentration of PLC-␤1 or PLC-␤2 markedly increased their relative stimulation by G␤␥ (31) . More recently, studies by Ball and Sternweis 2 of wild type PLC-␤2 and PLC-␤2 mutated in the catalytic domain have also suggested enzyme oligomerization.
The initial indication of self-association of PLC-␤1 COOH termini came from the combination of GTPase stimulation and inhibition shown in Fig. 3 . Some tails activated only, some enhanced activation by intact PLC-␤1, some blocked stimulation by PLC-␤1 or displayed decreasing GAP activity at high concentrations, and some exerted several of these effects. These effects appeared specific for each tail and generally appeared at concentrations of 1 M or less. Simple blockade of the GAP 2 R. Ball and P. C. Sternweis, submitted for publication. activity of PLC-␤1 (tail 32) or inhibition to a plateau characteristic of its own GAP activity (tail 3) can be explained by simple competitive binding to G q . However, initial potentiation of the GAP activity of PLC-␤1 followed by inhibition at higher concentration (tails 52 and 35) or intrinsic GAP activity that then reverses at higher concentrations (tail 35) demands at least two sites of action. The effects of the tails that are related to GAP activity and its inhibition do not distinguish whether the tails actually oligomerize with themselves or with PLC-␤1 or whether there are two binding sites for PLC on G q . However, the ability of the tails to inhibit the phospholipolytic activity of PLC-␤1 in the absence of G q argues independently that they act on PLC-␤1 directly, particularly because inhibition is overcome or reversed by activated G q in the case of tail 5, tail 35, and tail 52.
We therefore favor the ideas that the tails can form oligomers with themselves or with PLC-␤1 and that oligomerization of PLC-␤1 itself is of regulatory importance. The present data provide the basis for designing protein-protein binding assays to test oligomerization directly. 
TABLE I
Regulatory effects of the PLC-␤1 tails Effects are qualitatively described as clear (ϩ), minor (Ϯ), or near zero (Ϫ). Note that although intrinsic GAP activity and potentiation of the GAP activity of PLC-␤1 occurs over the same range of tail concentrations, inhibition of GAP activity occurs at higher concentrations (Fig. 2) . Tail (Fig. 4 ).
